Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2026-05-07 Delisting Announcement
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
기타시장안내 (상장폐지 절차 진행 안내)
Delisting Announcement Classification · 100% confidence The document is a notice regarding the delisting procedure of the company 아퓨어스(주) due to an audit opinion issue ('opinion refusal' related to going concern uncertainty) and the failure to submit a confirmation letter by the deadline. It mentions the initiation of delisting procedures according to market regulations and the termination of a designated advisor contract. The document is short (606 characters) and serves as an official announcement about the delisting process rather than a detailed report or financial statement. Therefore, it fits the category of a Delisting Announcement (DLST).
2026-05-07 Korean
주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)
Delisting Announcement Classification · 100% confidence The document is a notice regarding the lifting of a trading suspension for a stock due to the commencement of a delisting-related orderly sale period. It references delisting reasons, dates for the orderly sale period, and the delisting date. This matches the definition of a Delisting Announcement (DLST), which is an official notice that the company's stock will be removed from an exchange. The document is short and focused solely on this announcement, not a full report or other filing type.
2026-05-07 Korean
주권매매거래정지기간변경 (상장폐지사유 발생)
Regulatory Filings Classification · 90% confidence The document is a short regulatory notice in Korean detailing the change of the trading suspension period (주권매매거래정지 기간변경) due to delisting conditions under Konex market rules. It is not a financial report, earnings release, proxy statement, or management change. It fits the fallback category for miscellaneous regulatory announcements (Regulatory Filings).
2026-04-13 Korean
기타시장안내 (상장폐지 관련)
Delisting Announcement Classification · 93% confidence The document is titled “기타시장안내(상장폐지 관련)” and describes that the company received notice to delist from the KONEX market due to a disclaimer of audit opinion, including the timeline for appeal. This is an official notice of delisting. Therefore, it matches Delisting Announcement (Code: DLST).
2026-04-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is a notice of results from the 2026 regular shareholders’ (AGM) meeting, detailing votes on agenda items (financial statements approval, director/auditor elections, etc.) and showing voting outcomes. This corresponds to declaration of voting results at a general meeting, which maps to the Declaration of Voting Results & Voting Rights Announcement category (DVA).
2026-03-31 Korean
지정자문인선임계약의해지
Regulatory Filings Classification · 75% confidence The document is an announcement of the termination of a designated advisor appointment contract (키움증권) rather than a financial report, management change, dividend, or share transaction. It does not fit any specific category and is a general regulatory disclosure, making it a fallback Regulatory Filing (RNS).
2026-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.